$11.06
-0.07-0.58%
Last update: 1:52 PM
15 minutes delayed
Roivant Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Roivant Sciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ROIV | Roivant Sciences | -$0.38 | -$0.26 | — | — | $21.62M | $31.60M | — | — | 08/12/2024 | Get Alert |
ROIV | Roivant Sciences | -$0.20 | -$0.30 | -$0.19 | 36.67% | $27.38M | $32.10M | $28.93M | -9.88% | 05/30/2024 | Get Alert |
ROIV | Roivant Sciences | -$0.49 | -$0.32 | -$0.21 | 34.38% | $17.05M | $32.79M | $37.14M | 13.27% | 02/13/2024 | Get Alert |
ROIV | Roivant Sciences | -$0.42 | -$0.31 | -$0.40 | -29.03% | $12.53M | $30.12M | $37.10M | 23.19% | 11/13/2023 | Get Alert |
ROIV | Roivant Sciences | -$0.48 | -$0.30 | -$0.38 | -26.67% | $4.32M | $25.07M | $21.62M | -13.75% | 08/14/2023 | Get Alert |
ROIV | Roivant Sciences | -$0.39 | -$0.36 | -$0.20 | 44.44% | $9.22M | $21.53M | $27.38M | 27.15% | 06/28/2023 | Get Alert |
ROIV | Roivant Sciences | -$0.41 | -$0.39 | -$0.49 | -25.64% | $24.34M | $14.64M | $17.05M | 16.48% | 02/13/2023 | Get Alert |
ROIV | Roivant Sciences | -$0.32 | -$0.41 | -$0.42 | -2.44% | $13.99M | $5.70M | $12.53M | 119.88% | 11/14/2022 | Get Alert |
ROIV | Roivant Sciences | -$0.13 | -$0.32 | -$0.48 | -50.00% | $7.74M | $7.74M | $4.32M | -44.16% | 08/15/2022 | Get Alert |
ROIV | Roivant Sciences | -$0.80 | -$0.32 | -$0.39 | -21.88% | $15.15M | $13.35M | $9.22M | -30.91% | 06/28/2022 | Get Alert |
ROIV | Roivant Sciences | -$0.41 | -$0.25 | -$0.41 | -64.00% | $5.75M | $9.87M | $24.34M | 146.62% | 02/14/2022 | Get Alert |
ROIV | Roivant Sciences | -$0.06 | -$0.15 | -$0.26 | -73.33% | $1.32M | $6.94M | $13.99M | 101.54% | 11/15/2021 | Get Alert |
ROIV | Roivant Sciences | -$0.02 | — | -$0.37 | — | $1.58M | — | $7.74M | — | 09/21/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-30 | $-0.19 | $-0.30 | 36.7 % |
Dec 2023 | 2024-02-13 | $-0.21 | $-0.32 | 34.4 % |
Sep 2023 | 2023-11-13 | $-0.40 | $-0.31 | -29.0 % |
Jun 2023 | 2023-08-14 | $-0.38 | $-0.30 | -26.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-30 | $28.93M | $32.10M | -9.88 % |
Dec 2023 | 2024-02-13 | $37.14M | $32.79M | 13.3 % |
Sep 2023 | 2023-11-13 | $37.10M | $30.12M | 23.2 % |
Jun 2023 | 2023-08-14 | $21.62M | $25.07M | -13.8 % |
Roivant Sciences (ROIV) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 30, 2024 for Q4.
The Actual EPS was $-0.19, which beat the estimate of $-0.30.
The Actual Revenue was $28.9M, which missed the estimate of $32.1M.
Browse earnings estimates, EPS, and revenue on all stocks.